Lena Börjesson

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Although the anti-inflammatory role of the A2a receptor is well established, controversy remains with regard to the therapeutic value for A2a agonists in treatment of inflammatory lung diseases, also as a result of unwanted A2a-mediated cardiovascular effects. In this paper, we describe the discovery and characterization of a new, potent and selective A2a(More)
  • 1